{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:03:47Z","timestamp":1789473827778,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.diabres.2011.08.021","type":"journal-article","created":{"date-parts":[[2011,9,11]],"date-time":"2011-09-11T04:21:16Z","timestamp":1315714876000},"page":"269-275","source":"Crossref","is-referenced-by-count":21,"title":["Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals"],"prefix":"10.1016","volume":"94","author":[{"given":"Beatriz","family":"Hemo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Endevelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Porath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir J.","family":"Stampfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Shai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.diabres.2011.08.021_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00125-008-1157-y","article-title":"Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"52","author":"Nathan","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2011.08.021_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/epirev\/mxm007","article-title":"The obesity epidemic in the United States \u2013 gender, age, socioeconomic, racial\/ethnic, and geographic characteristics: a systematic review and meta-regression analysis","volume":"29","author":"Wang","year":"2007","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.diabres.2011.08.021_bib0015","series-title":"Obesity: preventing and managing the global epidemic [WHO Technical report series No. 894]","author":"World Health Organization","year":"2000"},{"key":"10.1016\/j.diabres.2011.08.021_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jama.1994.03520030047027","article-title":"Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991","volume":"272","author":"Kuczmarski","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2011.08.021_bib0025","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"BMJ"},{"issue":"7631","key":"10.1016\/j.diabres.2011.08.021_bib0030","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/bmj.39385.413113.25","article-title":"Long term pharmacotherapy for obesity and overweight: updated meta-analysis","volume":"335","author":"Rucker","year":"2007","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.diabres.2011.08.021_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002018-200831010-00005","article-title":"Orlistat-associated adverse effects and drug interactions: a critical review","volume":"31","author":"Filippatos","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.diabres.2011.08.021_bib0040","unstructured":"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationfor PatientsandProviders\/ucm191652.htm."},{"key":"10.1016\/j.diabres.2011.08.021_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"issue":"August (8)","key":"10.1016\/j.diabres.2011.08.021_bib0050","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.diabres.2011.08.021_bib0055","unstructured":"National Institute for Health and Clinical Excellence. CG43 obesity: full guideline, section 1-introduction, methods and recommendations, http:\/\/guidance.nice.org.uk\/CG43\/guidance\/section1\/word\/English; 2006."},{"issue":"4","key":"10.1016\/j.diabres.2011.08.021_bib0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/oby.2001.30","article-title":"Weight loss and gender: an examination of physician attitudes","volume":"9","author":"Anderson","year":"2001","journal-title":"Obes Res"},{"issue":"April (2)","key":"10.1016\/j.diabres.2011.08.021_bib0065","first-page":"CD000011","article-title":"Interventions for enhancing medication adherence","volume":"16","author":"Haynes","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.diabres.2011.08.021_bib0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cnur.2007.10.006","article-title":"Medication adherence in patients who have heart failure: a review of the literature","volume":"43","author":"Wu","year":"2008","journal-title":"Nurs Clin North Am"},{"issue":"4","key":"10.1016\/j.diabres.2011.08.021_bib0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MAJ.0b013e318068dde8","article-title":"Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review","volume":"334","author":"Gossec","year":"2007","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.diabres.2011.08.021_bib0080","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/archinte.163.9.1046","article-title":"National trends in antiobesity medication use","volume":"163","author":"Stafford","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabres.2011.08.021_bib0085","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/sj.ijo.0803631","article-title":"Long-term persistence with orlistat and sibutramine in a population-based cohort","volume":"31","author":"Padwal","year":"2007","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"10.1016\/j.diabres.2011.08.021_bib0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/pubmed\/fdm013","article-title":"National trends in the use and costs of anti-obesity medications in England 1998\u20132005","volume":"29","author":"Srishanmuganathan","year":"2007","journal-title":"J Public Health (Oxf)"},{"issue":"11","key":"10.1016\/j.diabres.2011.08.021_bib0095","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/oby.2005.234","article-title":"Trends in obesity and overweight-related office visits and drug prescriptions in Canada, 1998 to 2004","volume":"13","author":"Padwal","year":"2005","journal-title":"Obes Res"},{"issue":"3","key":"10.1016\/j.diabres.2011.08.021_bib0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa0708681","article-title":"Weight loss with a low-carbohydrate Mediterranean, or low-fat diet","volume":"359","author":"Shai","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.diabres.2011.08.021_bib0105","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11883-007-0061-0","article-title":"Pharmacotherapy for obesity","volume":"9","author":"Neff","year":"2007","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.diabres.2011.08.021_bib0110","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults \u2013 the evidence report: National Institutes of Health","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.diabres.2011.08.021_bib0115","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archfami.9.7.631","article-title":"National patterns of physician activities related to obesity management","volume":"9","author":"Stafford","year":"2000","journal-title":"Arch Fam Med"},{"issue":"6","key":"10.1016\/j.diabres.2011.08.021_bib0120","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11096-010-9432-7","article-title":"Cardiovascular comedication among users of antiobesity drugs: a population-based study","volume":"32","author":"Amundsen","year":"2010","journal-title":"Pharm World Sci"},{"issue":"10","key":"10.1016\/j.diabres.2011.08.021_bib0125","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/sj.ijo.0803631","article-title":"Long-term persistence with orlistat and sibutramine in a population-based cohort","volume":"31","author":"Padwal","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.diabres.2011.08.021_bib0130","doi-asserted-by":"crossref","first-page":"179674","DOI":"10.1155\/2011\/179674","article-title":"Pharmacotherapies for obesity: past, current, and future therapies","volume":"2011","author":"Ioannides-Demos","year":"2011","journal-title":"J Obes"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822711004669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822711004669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T05:24:12Z","timestamp":1560576252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822711004669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0168822711004669"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2011.08.021","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}